1. Influenza

   • Peter Cram
   • Susan G. Blitz
   • A. Mark Fendrick

   Leading Article 21 September 2012 Pages: 223 - 230

   

2. Workplace Productivity

   • Paul Stang
   • Roger Cady
   • Lynn Hoffman

   Review Article 21 September 2012 Pages: 231 - 244

   

3. Economic Burden of Chronic Obstructive Pulmonary Disease

   • Mitchell Friedman
   • Daniel E. Hilleman

   Review Article 21 September 2012 Pages: 245 - 254

   

4. Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries

   • Carlos Gouveia Pinto
   • Antoine Lafuma
   • Gilles Berdeaux

   Original Research Article 21 September 2012 Pages: 255 - 265

   

5. Cost of Treatment for Onychomycosis

   • David M. Stier
   • Curt Henke
   • Jeanette Broering

   Original Research Article 21 September 2012 Pages: 267 - 279

   

6. Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel

   • Gabriel Chodick
   • Yehuda Lerman
   • Shai Ashkenazi

   Original Research Article 21 September 2012 Pages: 281 - 291

   

7. Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

   • Adrian D. Griffin
   • Andrew S. Perry
   • Douglas M. Fleming

   Original Research Article 21 September 2012 Pages: 293 - 301

   

8. Rivastigmine

   • Harriet M. Lamb
   • Karen L. Goa

   Adis Pharmacoeconomic Drug Evaluation 21 September 2012 Pages: 303 - 318